| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/HRT.2007.122325 |
| P698 | PubMed publication ID | 18070940 |
| P2093 | author name string | S J Lewis | |
| D M Herrington | |||
| F K Welty | |||
| N K Wenger | |||
| TNT Steering Committee and Investigators | |||
| V Bittner | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | LDL cholesterol | Q75298271 |
| heart disease | Q190805 | ||
| coronary artery disease | Q844935 | ||
| P304 | page(s) | 434-439 | |
| P577 | publication date | 2007-12-10 | |
| P1433 | published in | Heart | Q856338 |
| P1476 | title | Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study | |
| P478 | volume | 94 |
| Q34990278 | Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22 |
| Q37269396 | Cardiovascular disease prevention tailored for women |
| Q46056160 | Does pay for performance improve cardiovascular care in a "real-world" setting? |
| Q36009362 | Drivers of the Sex Disparity in Statin Therapy in Patients with Coronary Artery Disease: A Cohort Study |
| Q37079118 | Drugs for cardiovascular disease prevention in women: implications of the AHA Guidelines--2007 Update |
| Q24194514 | HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis |
| Q37478992 | Highly sensitive C-reactive protein, body mass index, and serum lipids in HIV-infected persons receiving antiretroviral therapy: a longitudinal study |
| Q89903377 | Pharmacological interventions for heart failure in people with chronic kidney disease |
| Q38500893 | Primary and secondary prevention of ischemic heart disease in women |
| Q54203490 | Reduction of Vascular Inflammation, LDL-C, or Both for the Protection from Cardiovascular Events? |
| Q37448924 | Review of the treatment of acute coronary syndrome in elderly patients |
| Q35631575 | Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastati |
| Q41856851 | Tailoring cardiovascular risk assessment and prevention for women: One size does not fit all. |
Search more.